Literature DB >> 24521856

Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections.

Alessandra Oliva1, Alessandra D'Abramo1, Claudia D'Agostino1, Marco Iannetta1, Maria T Mascellino1, Carmela Gallinelli1, Claudio M Mastroianni2, Vincenzo Vullo1.   

Abstract

Entities:  

Keywords:  KPC; bacteraemia; ertapenem; meropenem; nosocomial infections

Mesh：

Substances：

Year:  2014        PMID： 24521856     DOI： 10.1093/jac/dku027

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  26 in total

1.  Every cloud has a silver lining.

Authors:  Filippo Pieralli; Silvia Baroncelli; Alberto Farese; Antonio Mancini; Fabio Luise; Lucia Sammicheli; Alessandro Bartoloni; Gian Maria Rossolini; Carlo Nozzoli
Journal:  Intern Emerg Med       Date:  2017-05-10       Impact factor: 3.397

Review 2.  Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.

Authors:  Elizabeth A Neuner; Jason C Gallagher
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

3.  Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae.

Authors:  M Souli; I Karaiskos; A Masgala; L Galani; E Barmpouti; H Giamarellou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-16       Impact factor: 3.267

Review 4.  Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.

Authors:  Enrico Maria Trecarichi; Mario Tumbarello
Journal:  Virulence       Date:  2017-02-08       Impact factor: 5.882

Review 5.  Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.

Authors:  Vindana Chibabhai; Trusha Nana; Norma Bosman; Teena Thomas; Warren Lowman
Journal:  Infection       Date:  2017-09-15       Impact factor: 3.553

Review 6.  The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms.

Authors:  Ann Marie Porreca; Kaede V Sullivan; Jason C Gallagher
Journal:  Curr Infect Dis Rep       Date:  2018-05-05       Impact factor: 3.725

Review 7.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

8.  Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.

Authors:  Jose F Camargo; Jacques Simkins; Thiago Beduschi; Akin Tekin; Laura Aragon; Armando Pérez-Cardona; Clara E Prado; Michele I Morris; Lilian M Abbo; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2015-10       Impact factor: 5.191

9.  In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.

Authors:  J Córdoba; N M Coronado-Álvarez; D Parra; J Parra-Ruiz
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

Review 10.  New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies.

Authors:  Sara Lo Menzo; Giulia la Martire; Giancarlo Ceccarelli; Mario Venditti
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-07-01       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.